Neuroleptics, also known as antipsychotics, are medications primarily used to manage behavioral symptoms like agitation, aggression, and psychosis in Alzheimer's disease and dementia patients. However, their use is controversial due to potential side effects such as sedation, increased risk of falls, and cognitive decline. Neuroleptics work by blocking dopamine receptors in the brain, which can help alleviate symptoms but may also worsen cognitive function in elderly individuals already vulnerable to cognitive impairment.
Recent guidelines emphasize cautious and limited use of neuroleptics, preferring non-pharmacological approaches first. Behavioral interventions, environmental modifications, and caregiver education are preferred strategies to manage challenging behaviors. When neuroleptics are prescribed, it is crucial to monitor their effects closely and consider the individual's overall health and specific needs. Balancing the benefits against potential risks remains essential in optimizing care for Alzheimer's and dementia patients.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States